1. Regeneron starting late stage trials of coronavirus drug cocktail — Bristol-Myers pays Dragonfly Therapeutics $55M to bring NK cells to neuro diseases — JNJ in $480M-plus deal with Emergent for coronavirus vaccine supply — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Word is out.

Discussion in 'CSI Laboratories' started by anonymous, Jun 10, 2017 at 12:47 AM.

  1. anonymous

    anonymous Guest

    Hey Ron, there's a mole inside or closely related to CSI who's telling folks you're in a lot deep doo financially. Says you're trying to hide it. Hmmmmm......says others near the top know this. She usually is reliable. Oh well..............